Cargando…

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety

SIMPLE SUMMARY: This study aimed to describe treatment efficacy and safety in patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiation therapy (SBRT). In one of the largest retrospective studies to date, we analyzed the data of 318 patients. The median follow-up period was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roquette, Isaure, Bogart, Emilie, Lacornerie, Thomas, Ningarhari, Massih, Bibault, Jean-Emmanuel, Le Deley, Marie-Cecile, Lartigau, Eric F., Pasquier, David, Mirabel, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405555/ https://www.ncbi.nlm.nih.gov/pubmed/36010885 http://dx.doi.org/10.3390/cancers14163892

Ejemplares similares

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2013)

Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2012)

Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
por: Dewas, Sylvain, et al.
Publicado: (2012)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
por: Fumagalli, Ingrid, et al.
Publicado: (2012)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
por: Taillez, Alexandre, et al.
Publicado: (2021)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015)

GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy—study protocol
por: Pasquier, David, et al.
Publicado: (2019)

Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
por: Dewas, Sylvain, et al.
Publicado: (2011)

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol
por: Pasquier, David, et al.
Publicado: (2018)

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
por: Leroy, Thomas, et al.
Publicado: (2017)

Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series
por: Fessart, Etienne, et al.
Publicado: (2020)

Adjuvant radiation therapy in metastatic lymph nodes from melanoma
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2011)

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study
por: Latorzeff, Igor, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer: A Retrospective Multicenter Study
por: Lemoine, Pauline, et al.
Publicado: (2021)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
por: Martinage, Geoffrey, et al.
Publicado: (2019)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms
por: Lacornerie, Thomas, et al.
Publicado: (2014)

Chest Magnetic Resonance Imaging Decreases Inter-observer Variability of Gross Target Volume for Lung Tumors
por: Basson, Laurent, et al.
Publicado: (2019)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)
por: Pasquier, David, et al.
Publicado: (2017)

Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking
por: Jarraya, Hajer, et al.
Publicado: (2013)

Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review
por: Tonneau, Marion, et al.
Publicado: (2021)

Feasibility Study of Pelvic Helical IMRT for Elderly Patients with Endometrial Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2014)

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
por: Pasquier, David, et al.
Publicado: (2023)

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey
por: Vilotte, F., et al.
Publicado: (2022)

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
por: Vaugier, Loïg, et al.
Publicado: (2021)

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients
por: Liu, Xiaojie, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

A biologically effective dose threshold for stereotactic body radiation therapy—can we put the issue to BED?
por: Mix, Michael, et al.
Publicado: (2020)

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
por: Solberg, Timothy D., et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Accelerated partial breast irradiation using robotic radiotherapy: a dosimetric comparison with tomotherapy and three-dimensional conformal radiotherapy
por: Rault, Erwann, et al.
Publicado: (2016)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life
por: Pasquier, David, et al.
Publicado: (2019)

Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma
por: Zhang, Tao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ohnl1v56bun8j9jfgva63cnssu